Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Biota Pharmaceuticals Inc    NABI   US6295191091

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Biota Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of products to prevent and treat serious and potentially life-threatening infectious diseases.The Company currently has two Phase 2 clinical-stage product candidates in development: laninamivir... 
More about the company
Financials ($)
Sales 2015 34,4 M
EBIT 2015 -75,1 M
Net income 2015 -
Debt 2015 -
Yield 2015 -
Sales 2016 22,3 M
EBIT 2016 -34,7 M
Net income 2016 -
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 2,50x
Capi. / Sales 2016 3,86x
Capitalization 86,0 M
More Financials
Latest news on BIOTA PHARMACEUTICALS INC
10/01 BIOTA PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
09/30 BIOTA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
09/30 BIOTA PHARMACEUTICALS : Results of Operations and Financial Condition, Financial..
09/30 BIOTA PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8-..
09/29 BIOTA PHARMACEUTICALS : Reports Fourth Quarter and Fiscal Year-End 2014 Financia..
09/26 BIOTA PHARMACEUTICALS : Reports Fourth Quarter and Fiscal Year-End 2014 Financia..
09/26 BIOTA PHARMACEUTICALS : Announces Changes to Management and Board of Directors
09/15 BIOTA PHARMACEUTICALS : to Host Conference Call to Report Fourth Quarter and Yea..
09/04 BIOTA PHARMACEUTICALS : to Present Preclinical Data on RSV Compound BTA-C585 at ..
08/01 BIOTA PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8-..
08/01 BIOTA PHARMACEUTICALS : ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP..
08/01 BIOTA PHARMACEUTICALS : Reports Top-Line Data From Its Phase 2 "IGLOO" Trial of ..
More news
Comments 
Advertisement
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF